In The Fight To Bring Innovative Therapies To Patients

Building risk assessments and monitoring plans that focus on what is important into trial design lays the groundwork for a successful drug program by increasing data integrity and safeguarding patients. Our risk-based quality management (RBQM) capabilities ensure that:

• Risks to critical data and processes are identified early
• Functional areas each have unique and defined monitoring strategies
• A validated, closed system (TRI OPRA) manages the process with access control and a full audit trail
• A risk log that gives the option to add integrated forward looking indicators for Central Monitoring of potential risks in near real time

Download the available brochure to learn more.